HIV, malnutrition, and noncommunicable disease epidemics among tuberculosis-affected households in east and southern Africa: A cross-sectional analysis of the ERASE-TB cohort.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
16 Sep 2024
Historique:
received: 07 04 2024
accepted: 29 07 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: aheadofprint

Résumé

As a result of shared social and structural risk factors, people in households affected by tuberculosis may have an increased risk of chronic conditions; at the same time, tuberculosis screening may be an opportunity for interventions. We sought to describe the prevalence of HIV, nutritional disorders, and noncommunicable diseases (NCDs) among members of tuberculosis-affected households in 3 African countries. A part of a multicountry cohort study, we screened for tuberculosis, HIV, nutritional disorders (underweight, anaemia, overweight/obesity), and NCDs (diabetes, hypertension, and chronic lung disease) among members of tuberculosis-affected households aged ≥10 years in Mozambique, Tanzania, and Zimbabwe. We describe the prevalence of these conditions, their co-occurence within individuals (multimorbidity) and household-level clustering. Of 2,109 household contacts recruited, 92% (n = 1,958, from 786 households) had complete data and were included in the analysis. Sixty-two percent were female, median age was 27 years, and 0.7% (n = 14) were diagnosed with co-prevalent tuberculosis. Six percent of household members (n = 120) had previous tuberculosis, 15% (n = 294) were living with HIV, 10% (n = 194) had chronic lung disease, and 18% (n = 347) were anaemic. Nine percent of adults (n = 127) had diabetes by HbA1c criteria, 32% (n = 439) had hypertension. By body mass index criteria, 18% household members (n = 341) were underweight while 29% (n = 549) were overweight or obese. Almost half the household members (n = 658) had at least 1 modifiable tuberculosis risk factor. Sixty-one percent of adults (n = 822) had at least 1 chronic condition, one in 4 had multimorbidity. While most people with HIV knew their status and were on treatment, people with NCDs were usually undiagnosed and untreated. Limitations of this study include use of point-of-care HbA1c for definition of diabetes and definition of hypertension based on single-day measurements. Households affected by tuberculosis also face multiple other health challenges. Integrated approaches to tuberculosis screening may represent an opportunity for identification and treatment, including prioritisation of individuals at highest risk for tuberculosis to receive preventive therapy.

Sections du résumé

BACKGROUND BACKGROUND
As a result of shared social and structural risk factors, people in households affected by tuberculosis may have an increased risk of chronic conditions; at the same time, tuberculosis screening may be an opportunity for interventions. We sought to describe the prevalence of HIV, nutritional disorders, and noncommunicable diseases (NCDs) among members of tuberculosis-affected households in 3 African countries.
METHODS AND FINDINGS RESULTS
A part of a multicountry cohort study, we screened for tuberculosis, HIV, nutritional disorders (underweight, anaemia, overweight/obesity), and NCDs (diabetes, hypertension, and chronic lung disease) among members of tuberculosis-affected households aged ≥10 years in Mozambique, Tanzania, and Zimbabwe. We describe the prevalence of these conditions, their co-occurence within individuals (multimorbidity) and household-level clustering. Of 2,109 household contacts recruited, 92% (n = 1,958, from 786 households) had complete data and were included in the analysis. Sixty-two percent were female, median age was 27 years, and 0.7% (n = 14) were diagnosed with co-prevalent tuberculosis. Six percent of household members (n = 120) had previous tuberculosis, 15% (n = 294) were living with HIV, 10% (n = 194) had chronic lung disease, and 18% (n = 347) were anaemic. Nine percent of adults (n = 127) had diabetes by HbA1c criteria, 32% (n = 439) had hypertension. By body mass index criteria, 18% household members (n = 341) were underweight while 29% (n = 549) were overweight or obese. Almost half the household members (n = 658) had at least 1 modifiable tuberculosis risk factor. Sixty-one percent of adults (n = 822) had at least 1 chronic condition, one in 4 had multimorbidity. While most people with HIV knew their status and were on treatment, people with NCDs were usually undiagnosed and untreated. Limitations of this study include use of point-of-care HbA1c for definition of diabetes and definition of hypertension based on single-day measurements.
CONCLUSIONS CONCLUSIONS
Households affected by tuberculosis also face multiple other health challenges. Integrated approaches to tuberculosis screening may represent an opportunity for identification and treatment, including prioritisation of individuals at highest risk for tuberculosis to receive preventive therapy.

Identifiants

pubmed: 39283906
doi: 10.1371/journal.pmed.1004452
pii: PMEDICINE-D-24-01115
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1004452

Informations de copyright

Copyright: © 2024 Calderwood et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests: EDCTP Grant funding for this research to NH’s institution. DZIF Grant funding for this research to NH’s institution. Funding by Beckman Coulter to NH’s institution.

Auteurs

Claire Jacqueline Calderwood (CJ)

Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.
The Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe.

Edson Tawanda Marambire (ET)

The Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe.
CIHLMU Center for International Health, University Hospital, LMU Munich, Munich, Germany.

Leyla Larsson (L)

The Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe.
Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.

Denise Banze (D)

CIHLMU Center for International Health, University Hospital, LMU Munich, Munich, Germany.
Instituto Nacional de Saúde (INS), Marracuene, Mozambique.

Alfred Mfinanga (A)

CIHLMU Center for International Health, University Hospital, LMU Munich, Munich, Germany.
National Institute for Medical Research-Mbeya Medical Research Centre, Mbeya, Tanzania.

Celina Nhamuave (C)

Instituto Nacional de Saúde (INS), Marracuene, Mozambique.

Tejawsi Appalarowthu (T)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.

Mishelle Mugava (M)

The Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe.

Jorge Ribeiro (J)

Instituto Nacional de Saúde (INS), Marracuene, Mozambique.

Peter Edwin Towo (PE)

National Institute for Medical Research-Mbeya Medical Research Centre, Mbeya, Tanzania.

Karlos Madziva (K)

The Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe.

Justin Dixon (J)

Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Kathrin Held (K)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
German Centre for Infection Research (DZIF), partner site Munich, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology, Infection and Pandemic Research, Munich, Germany.

Lilian Tina Minja (LT)

National Institute for Medical Research-Mbeya Medical Research Centre, Mbeya, Tanzania.

Junior Mutsvangwa (J)

Biomedical Research and Training Institute, Harare, Zimbabwe.

Celso Khosa (C)

Instituto Nacional de Saúde (INS), Marracuene, Mozambique.

Norbert Heinrich (N)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
German Centre for Infection Research (DZIF), partner site Munich, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology, Infection and Pandemic Research, Munich, Germany.

Katherine Fielding (K)

TB Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Katharina Kranzer (K)

Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.
The Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe.
Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
German Centre for Infection Research (DZIF), partner site Munich, Germany.

Classifications MeSH